港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

劲方医药-B

31.360

-0.640-2.00%

成交量：35.26万

成交额：1,112.52万

市值：116.03亿

市盈率：-15.87

高：32.280

开：32.020

低：30.800

收：32.000

52周最高：50.200

52周最低：24.320

股本：3.70亿

香港流通股本：3.38亿

量比：0.30

换手率：0.10%

股息：- -

股息率：- -

每股收益(LYR):-1.976

净资产收益率：--

总资产收益率：-30.27%

市净率：-4.02

市盈率(LYR):-15.87

市销率: 54.86

数据加载中...

总览公司新闻资讯公告

药企赴港IPO火爆，半个月8家递表，基石投资者“快看不过来了”

劲方医药-B11月14日获主力加仓80.3万元

劲方医药-B(02595.HK)尾盘涨超8%

每日经济新闻

港股异动 | 劲方医药-B(02595)尾盘涨超8% GFH375片启动III期临床适应症为转移性胰腺癌

劲方医药KRAS G12D药物开启一项Ⅲ期临床试验

劲方医药-B盘中异动急速上涨5.08%报30.600港元

劲方医药-B11月10日获主力加仓758.6万元

港股生物医药板块午后走强！歌礼制药-B涨超10%，圣诺医药-B涨超8%

老虎资讯综合

劲方医药-B10月30日主力净流出74.6万元散户资金买入

劲方医药-B10月27日获主力加仓37.1万元

劲方医药-B10月23日主力净流入174.2万元散户资金抛售

港股异动 | 劲方医药-B(02595)由跌转涨逾9% GFH375联合疗法治疗晚期实体瘤研究完成首例入组

智通财经网

劲方医药-B(02595)：KRAS G12D抑制剂GFH375联合西妥昔单抗或化疗治疗晚期实体瘤的Ib/II期研究完成首例患者给药

劲方医药-B(02595)10月21日因超额配股权获行使而发行1338.6万股

劲方医药-B10月21日遭主力抛售81.9万元

刷新港股18A纪录！国产RAS创新药龙头劲方医药即将敲钟

劲方医药-B10月20日遭主力抛售284.6万元

劲方医药-B(02595)：悉数行使超额配股权、稳定价格期结束

多只医药新股上市头日收涨超100%！包括曾申报科创板IPO未果的新股

劲方医药GFH375片启动Ib/II期临床适应症为晚期实体瘤

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02595/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02595","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02595\",,,,,undefined,":{"symbol":"02595","market":"HK","secType":"STK","nameCN":"劲方医药-B","latestPrice":31.36,"timestamp":1763366893755,"preClose":32,"halted":0,"volume":352600,"delay":0,"floatShares":338000000,"shares":370000000,"eps":-1.976,"marketStatus":"已收盘","change":-0.64,"latestTime":"11-17 16:08:13","open":32.02,"high":32.28,"low":30.8,"amount":11125210,"amplitude":0.04625,"askPrice":31.48,"askSize":1800,"bidPrice":31.36,"bidSize":2200,"shortable":0,"etf":0,"ttmEps":-2.744,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1763429400000},"marketStatusCode":5,"adr":0,"listingDate":1758211200000,"exchange":"SEHK","adjPreClose":32,"openAndCloseTimeList":[[1763343000000,1763352000000],[1763355600000,1763366400000]],"volumeRatio":0.30164,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02595\",,,,,undefined,":{"symbol":"02595","floatShares":338000000,"roa":"-30.27%","roe":"--","lyrEps":-1.976,"volumeRatio":0.30164,"shares":370000000,"dividePrice":0,"high":32.28,"amplitude":0.04625,"preClose":32,"low":30.8,"week52Low":24.32,"pbRate":"-4.02","psRate":"54.86","week52High":50.2,"institutionHeld":0,"latestPrice":31.36,"committee":0.1,"eps":-1.976,"divideRate":0,"volume":352600,"delay":0,"ttmEps":-2.744,"open":32.02,"prevYearClose":20.39,"prevWeekClose":32,"prevMonthClose":27.32,"prevQuarterClose":40,"fiveDayClose":29.24,"twentyDayClose":31.8,"sixtyDayClose":20.39},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02595\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02595\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02595\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02595\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02595","date":"2025-11-14","current":-11.567055,"percent":0.405405,"low":-19.62221,"twenty":-18.558233,"median":-10.712517,"eighty":-9.936062,"high":-9.058573,"avg":-12.958612,"sd":3.82741,"marketCap":11851732160},"quantilePoints":[{"date":"2025-09-19","current":-19.62221,"twenty":-19.62221,"median":-19.62221,"eighty":-19.62221,"marketCap":14538840523},{"date":"2025-09-26","current":-17.850791,"twenty":-18.989349,"median":-18.569255,"eighty":-18.336187,"marketCap":13192012066},{"date":"2025-10-03","current":-19.06699,"twenty":-19.162092,"median":-18.845312,"eighty":-18.417026,"marketCap":14124431767},{"date":"2025-10-10","current":-11.809112,"twenty":-19.045684,"median":-18.645404,"eighty":-16.087956,"marketCap":11948785798},{"date":"2025-10-17","current":-10.861917,"twenty":-19.006201,"median":-18.336187,"eighty":-11.374297,"marketCap":10981832034},{"date":"2025-10-24","current":-9.567304,"twenty":-18.816504,"median":-12.899451,"eighty":-10.554523,"marketCap":9676444452},{"date":"2025-10-31","current":-9.989391,"twenty":-18.681528,"median":-11.762498,"eighty":-10.081819,"marketCap":10118416331},{"date":"2025-11-07","current":-9.878556,"twenty":-18.646705,"median":-10.725216,"eighty":-9.89625,"marketCap":9999899010},{"date":"2025-11-14","current":-11.674836,"twenty":-18.558233,"median":-10.712517,"eighty":-9.936062,"marketCap":11851732160}],"updateTime":1763348050549},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02595\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2583363717","title":"药企赴港IPO火爆，半个月8家递表，基石投资者“快看不过来了”","url":"https://stock-news.laohu8.com/highlight/detail?id=2583363717","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583363717?lang=zh_cn&edition=fundamental","pubTime":"2025-11-15 16:43","pubTimestamp":1763196217,"startTime":"0","endTime":"0","summary":"“我们正在中国香港进行IPO路演，但这段时间药企扎堆申报港股IPO，已形成了‘堰塞湖’，基石投资者和锚定投资者都快看不过来了，我们遭遇路演排队。”有赴港IPO药企人士对第一财经记者透露。今年以来，港股医药二级市场的复苏，提振了企业们IPO融资热情。根据Choice金融终端数据，截至11月14日，港股的医疗保健板块今年累计迎来了23家企业成功上市，而去年同期仅有8家企业上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"eastmoney_highlight","url":"http://hk.eastmoney.com/news/11792,202511153565388760.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://hk.eastmoney.com/news/11792,202511153565388760.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"eastmoney_highlight","symbols":["LU0572944931.SGD","LU1064130708.USD","LU1720050803.USD","LU2213484517.USD","LU1146622755.USD","LU1023057109.AUD","09606","LU1979443071.USD","LU2148510915.USD","LU2097828805.USD","GIC","SGXZ49509284.SGD","LU0605514214.HKD","HK0000500386.USD","LU0823426308.USD","LU1580142542.USD","LU1734074674.USD","02615","BK4104","LU2580892862.HKD","HK0000252152.HKD","LU1655091616.SGD","BK0196","LU0359201612.USD","688506","02591","600276","LU2097828474.EUR","LU1997244956.HKD","LU1064131003.USD","LU2153592121.USD","09887","HK0000252160.HKD","300760","SGXZ81163826.USD","LU0594300179.USD","LU1934453819.USD","BK1515","300558","02617","IE0031814852.USD","LU1688375341.USD","09939","LU0405327494.USD","LU2097828714.EUR","02595","LU1328615791.USD","IE00B29SXG58.USD","LU1781817850.SGD","LU2153591404.USD"],"gpt_icon":0},{"id":"2583686606","title":"劲方医药-B11月14日获主力加仓80.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583686606","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583686606?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 16:15","pubTimestamp":1763108141,"startTime":"0","endTime":"0","summary":"11月14日, 劲方医药-B股价涨2.37%，报收32.00元，成交金额5231.2万元，换手率0.48%，振幅13.69%，量比1.68。劲方医药-B今日主力资金净流入80.3万元，上一交易日主力净流入140.3万元。该股近5个交易日上涨18.52%，主力资金累计净流入1208.4万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入1212.5万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111416194295041427&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111416194295041427&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1515","02595","09939","BK1574"],"gpt_icon":0},{"id":"2583655101","title":"劲方医药-B(02595.HK)尾盘涨超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583655101","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583655101?lang=zh_cn&edition=fundamental","pubTime":"2025-11-13 16:04","pubTimestamp":1763021075,"startTime":"0","endTime":"0","summary":"每经AI快讯，劲方医药-B(02595.HK)尾盘涨超8%，截至发稿，涨7.46%，报31.1港元，成交额2808.49万港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511133563551168.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511133563551168.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09939","BK1515","BK1161","BK1574","02595"],"gpt_icon":0},{"id":"2583551384","title":"港股异动 | 劲方医药-B(02595)尾盘涨超8% GFH375片启动III期临床 适应症为转移性胰腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2583551384","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583551384?lang=zh_cn&edition=fundamental","pubTime":"2025-11-13 15:53","pubTimestamp":1763020410,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，劲方医药-B尾盘涨超8%，截至发稿，涨7.46%，报31.1港元，成交额2808.49万港元。消息面上，11月11日，药物临床试验登记与信息公示平台显示，劲方医药开启了一项比较GFH375单药与研究者选择化疗治疗KRAS G12D突变型经治转移性胰腺癌患者的有效性及安全性/耐受性的多中心、开放标签、随机对照的III期临床研究。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1368752.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09939","BK1161","III","159938","BK1574","BK4134","BK1515","02595"],"gpt_icon":0},{"id":"2583530544","title":"劲方医药KRAS G12D药物开启一项Ⅲ期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2583530544","media":"药渡","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583530544?lang=zh_cn&edition=fundamental","pubTime":"2025-11-12 11:06","pubTimestamp":1762916765,"startTime":"0","endTime":"0","summary":"随着KRAS G12C突变体蛋白调控口袋的发现，以及2021年全球首款针对KRAS G12C突变靶向药物来自安进的索托拉西布的获批，才开启了KRAS靶向治疗的新纪元。今年1月14日Verastem Inc获得劲方医药科技（上海）股份有限公司关于VS-7375的独家许可(生效)图片来源：药渡数据目前在全部针对KRAS G12D的在研药物中劲方医药GFH375与恒瑞医药的HRS-4642处于领先地位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112112827a6f3612c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112112827a6f3612c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09939","BK1161","02595","BK1515"],"gpt_icon":0},{"id":"2583305412","title":"劲方医药-B盘中异动 急速上涨5.08%报30.600港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583305412","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583305412?lang=zh_cn&edition=fundamental","pubTime":"2025-11-12 10:24","pubTimestamp":1762914281,"startTime":"0","endTime":"0","summary":"2025年11月12日早盘10时24分，劲方医药-B股票出现异动，股价大幅拉升5.08%。截至发稿，该股报30.600港元/股，成交量33.86万股，换手率0.10%，振幅5.43%。资金方面，该股资金流入701.749万港元，流出270.354万港元。劲方医药-B股票所在的药品行业中，整体涨幅为1.16%。其相关个股中，三生制药、中国同辐、劲方医药-B涨幅较大，振幅较大的相关个股有三爱健康集团、三生制药、先声药业，振幅分别为13.56%、8.29%、6.15%。该公司主要在中国国内和海外市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112102441a6f33e1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112102441a6f33e1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02595","BK1161","BK1574","BK1515","09939"],"gpt_icon":0},{"id":"2582138458","title":"劲方医药-B11月10日获主力加仓758.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582138458","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582138458?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 16:15","pubTimestamp":1762762538,"startTime":"0","endTime":"0","summary":"11月10日, 劲方医药-B股价涨8.30%，报收29.24元，成交金额4970.8万元，换手率0.50%，振幅14.44%，量比3.83。劲方医药-B今日主力资金净流入758.6万元，连续4日净流入，上一交易日主力净流入37.3万元。该股近5个交易日上涨6.91%，主力资金累计净流入1296.7万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入605.4万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110161902975fcea3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110161902975fcea3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02595","09939","BK1574","BK1161","BK1515"],"gpt_icon":0},{"id":"1133726470","title":"港股生物医药板块午后走强！歌礼制药-B涨超10%，圣诺医药-B涨超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133726470","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133726470?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 14:00","pubTimestamp":1762754453,"startTime":"0","endTime":"0","summary":"11月10日，港股生物医药板块午后走强，$歌礼制药-B(01672)$涨超10%，$圣诺医药-B(02257)$涨超8%，银诺医药-B、开拓药业-B、$劲方医药-B(02595)$、$映恩生物-B(09606)$涨超5%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"afa821d7c5aabc22fa508f3ca44a801f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","02257","09606","02591","02595","09939","01477"],"gpt_icon":0},{"id":"2579710170","title":"劲方医药-B10月30日主力净流出74.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2579710170","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579710170?lang=zh_cn&edition=fundamental","pubTime":"2025-10-30 16:15","pubTimestamp":1761812117,"startTime":"0","endTime":"0","summary":"10月30日, 劲方医药-B股价跌5.88%，报收26.58元，成交金额1281.2万元，换手率0.14%，振幅6.66%，量比0.39。劲方医药-B今日主力资金净流出74.6万元，上一交易日主力净流出0万元。该股近5个交易日上涨0.53%，主力资金累计净流入181.3万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出148.0万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103016160294e5213a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103016160294e5213a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09939","BK1161","02595","BK1515"],"gpt_icon":0},{"id":"2578986872","title":"劲方医药-B10月27日获主力加仓37.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2578986872","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578986872?lang=zh_cn&edition=fundamental","pubTime":"2025-10-27 16:16","pubTimestamp":1761552965,"startTime":"0","endTime":"0","summary":"10月27日, 劲方医药-B股价涨2.50%，报收28.72元，成交金额1260.1万元，换手率0.13%，振幅5.57%，量比0.29。劲方医药-B今日主力资金净流入37.1万元，连续3日净流入，上一交易日主力净流入44.6万元。该股近5个交易日下跌8.29%，主力资金累计净流入59.9万元；近20日主力资金累计净流出711.6万元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251027162316a6d04bf2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251027162316a6d04bf2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","09939","BK1515","02595"],"gpt_icon":0},{"id":"2577584296","title":"劲方医药-B10月23日主力净流入174.2万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2577584296","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577584296?lang=zh_cn&edition=fundamental","pubTime":"2025-10-23 16:15","pubTimestamp":1761207342,"startTime":"0","endTime":"0","summary":"10月23日, 劲方医药-B股价涨12.22%，报收29.76元，成交金额5535.3万元，换手率0.62%，振幅25.19%，量比1.33。劲方医药-B今日主力资金净流入174.2万元，上一交易日主力净流出114.1万元。该股近5个交易日下跌3.85%，主力资金累计净流出541.1万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出1242.8万元，其中净流出天数为12日。该股主力净额占比0.02%，港股市场排名271/2682。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023161930a47030d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023161930a47030d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","09939","BK1161","02595","BK1574"],"gpt_icon":0},{"id":"2577789573","title":"港股异动 | 劲方医药-B(02595)由跌转涨逾9% GFH375联合疗法治疗晚期实体瘤研究完成首例入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2577789573","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577789573?lang=zh_cn&edition=fundamental","pubTime":"2025-10-23 15:17","pubTimestamp":1761203842,"startTime":"0","endTime":"0","summary":"消息面上，劲方医药宣布，旗下口服高活性及高选择性小分子KRAS G12D抑制剂GFH375，联合疗法用于治疗KRAS G12D突变型晚期实体瘤的Ib/II期研究，首例患者已在北京大学肿瘤医院完成入组。该项研究今年9月获得国家药监局临床试验批准，涉及联合西妥昔单抗或化疗两项联合疗法，其中GFH375联合化疗方案为一线胰腺导管腺癌治疗方案。报告聚焦该试验600 mgQD剂量组PDAC患者的研究数据，显示GFH375治疗PDAC患者的疗效突出且安全性可控。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1358628.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02595","BK1515","159938","BK1574","BK1161","09939"],"gpt_icon":0},{"id":"2577198386","title":"劲方医药-B(02595)：KRAS G12D抑制剂GFH375联合西妥昔单抗或化疗治疗晚期实体瘤的Ib/II期研究完成首例患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2577198386","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577198386?lang=zh_cn&edition=fundamental","pubTime":"2025-10-22 07:34","pubTimestamp":1761089667,"startTime":"0","endTime":"0","summary":"智通财经APP讯，劲方医药-B 发布公告，GFH375联合疗法治疗KRAS G12D突变型晚期实体瘤的Ib/II期研究首例患者在北京大学肿瘤医院完成入组。Ib期试验将首先在北京大学肿瘤医院等约15家中心开展，整体试验的主要研究目的为评估GFH375联合西妥昔单抗或化疗两项联合疗法在实体瘤患者中的安全性╱耐受性、疗效和药代动力学特征。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1357858.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1161","02595","159938","BK1574","09939"],"gpt_icon":1},{"id":"2577847319","title":"劲方医药-B(02595)10月21日因超额配股权获行使而发行1338.6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2577847319","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577847319?lang=zh_cn&edition=fundamental","pubTime":"2025-10-21 16:33","pubTimestamp":1761035615,"startTime":"0","endTime":"0","summary":"智通财经APP讯，劲方医药-B(02595)发布公告，于2025年10月21日因超额配股权获悉数行使而发行及配发1338.6万股H股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1357532.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02595","BK1574","09939","BK1515","159938","BK1161"],"gpt_icon":0},{"id":"2577353888","title":"劲方医药-B10月21日遭主力抛售81.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577353888","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577353888?lang=zh_cn&edition=fundamental","pubTime":"2025-10-21 16:16","pubTimestamp":1761034569,"startTime":"0","endTime":"0","summary":"10月21日, 劲方医药-B股价跌6.37%，报收29.38元，成交金额3006.1万元，换手率0.30%，振幅9.31%，量比0.73。劲方医药-B今日主力资金净流出81.9万元，连续6日净流出，上一交易日主力净流出284.6万元。该股近5个交易日下跌5.09%，主力资金累计净流出882.8万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出2700.0万元，其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021162256a6c57539&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021162256a6c57539&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02595","09939","BK1574","BK1515","BK1161"],"gpt_icon":0},{"id":"2577358057","title":"刷新港股18A纪录！国产RAS创新药龙头劲方医药即将敲钟","url":"https://stock-news.laohu8.com/highlight/detail?id=2577358057","media":"动脉网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577358057?lang=zh_cn&edition=fundamental","pubTime":"2025-10-21 15:48","pubTimestamp":1761032919,"startTime":"0","endTime":"0","summary":"基石投资者认购总额已达1亿美元，也创2022年以来港股 18A 生物科技公司新高。氟泽雷塞于2024年8月上市，为中国首个、全球第三个获批上市的KRAS G12C抑制剂。NSCLC、CRC、PDAC发病人数持续攀升。作为全球首个KRAS+EGFR一线肺癌联合疗法，其总体疗效优秀，且具有显著的脑转移肿瘤缓解、优于氟泽雷塞二线单药治疗的安全性。此外，GFH375有望与劲方的泛RAS抑制剂、EGFR-Pan RAS偶联药物，以及恶病质双抗GFS202A在未来形成狙击胰腺癌的疗法矩阵。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021161810a6c572b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251021161810a6c572b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09939","02595","06978","BK1515","BK1574"],"gpt_icon":0},{"id":"2576863005","title":"劲方医药-B10月20日遭主力抛售284.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576863005","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576863005?lang=zh_cn&edition=fundamental","pubTime":"2025-10-20 16:15","pubTimestamp":1760948154,"startTime":"0","endTime":"0","summary":"10月20日, 劲方医药-B股价跌1.32%，报收31.38元，成交金额3853.4万元，换手率0.37%，振幅6.10%，量比0.92。劲方医药-B今日主力资金净流出284.6万元，连续5日净流出，上一交易日主力净流出234.7万元。该股近5个交易日下跌8.63%，主力资金累计净流出906.5万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出2618.1万元，其中净流出天数为12日。该股主力净额占比0.03%，港股市场排名2542/2681。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251020162043a6c3533f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251020162043a6c3533f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02595","09939","BK1161","BK1515","BK1574"],"gpt_icon":0},{"id":"2575674517","title":"劲方医药-B(02595)：悉数行使超额配股权、稳定价格期结束","url":"https://stock-news.laohu8.com/highlight/detail?id=2575674517","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575674517?lang=zh_cn&edition=fundamental","pubTime":"2025-10-16 20:05","pubTimestamp":1760616345,"startTime":"0","endTime":"0","summary":"智通财经APP讯，劲方医药-B(02595)发布公告，独家保荐人兼整体协调人(为其本身及代表国际包销商)已于2025年10月16日悉数行使招股章程所述的超额配股权，涉及合共1338.6万股H股，占于任何超额配股权获行使前全球发售项下可供认购发售股份总数约15%(经计及发售量调整权获悉数行使)。超额配发股份将由公司按每股H股20.39港元发行及配发。超额配发股份将用于补足国际发售的超额分配。 此外，有关全球发售的稳定价格期已于2025年10月16日(即递交香港公开发售申请截止日期后第30日)结束。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1356044.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02595","BK1161","159938","09939","BK1515","BK1574"],"gpt_icon":0},{"id":"2575530714","title":"多只医药新股上市头日收涨超100%！包括曾申报科创板IPO未果的新股","url":"https://stock-news.laohu8.com/highlight/detail?id=2575530714","media":"制药网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575530714?lang=zh_cn&edition=fundamental","pubTime":"2025-10-16 16:58","pubTimestamp":1760605089,"startTime":"0","endTime":"0","summary":"银诺医药的暴涨更凸显了市场对核心创新资产的追捧。中国已成为全球第二大医药市场，其中创新药领域增长尤为迅猛。医药研发具有周期长、投入大、风险高的特点，一款新药从临床前研究到上市平均需投入 10 亿美元以上，成功率不足 10%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016170328a462f942&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016170328a462f942&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02595","02575","BK1161","09939","00460","BK1515","BK1574"],"gpt_icon":1},{"id":"2574517334","title":"劲方医药GFH375片启动Ib/II期临床 适应症为晚期实体瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=2574517334","media":"新浪财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574517334?lang=zh_cn&edition=fundamental","pubTime":"2025-10-11 18:03","pubTimestamp":1760176980,"startTime":"0","endTime":"0","summary":"药物临床试验登记与信息公示平台数据显示，劲方医药科技（上海）有限公司的一项多中心、开放标签，探索GFH375联合西妥昔单抗或AG在实体瘤参与者中的安全性/耐受性、PK特征，探索联合用药疗效的Ib/II期临床研究已启动。该药物剂型为片剂，规格为100mg/片，用法为口服，按方案规定使用。GFH375片为化学药物，适应症为晚期实体瘤。晚期实体瘤指癌细胞已扩散至身体其他部位的肿瘤，症状因肿瘤类型而异，常见有疼痛、消瘦等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101119070594c3121b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101119070594c3121b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02595","09939","BK1574","BK1161","BK1515"],"gpt_icon":1}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":73,"code":"91000000","status":"200"}]}}